Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Ines Bojanić"'
Publikováno v:
Liječnički vjesnik, Vol 144, Iss 5-6, Pp 169-172 (2022)
Introduction: COVID-19 pandemic brought challenges in the organization of hematopoietic stem cell (HSC) transplantation. Availability of HSCs was decreased due to donor infection and transport limitations. Accordingly, a series of measures was introd
Externí odkaz:
https://doaj.org/article/ec06c0e54e2c44dabe8aa1f797a0de62
Autor:
Vladimira Rimac, Ines Bojanić
Publikováno v:
International journal of laboratory hematologyREFERENCES. 44(3)
Cellular therapy nowadays includes various products from haematopoietic stem cells (HSC) collected from bone marrow, peripheral blood, and umbilical cord blood to more complex adoptive immune therapy for the treatment of malignant diseases, and gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d98c655b12947b17ea42faf8d1e6f305
https://pubmed.ncbi.nlm.nih.gov/35419954
https://pubmed.ncbi.nlm.nih.gov/35419954
Autor:
Ines Bojanić, Marija Lukić, Fini Plenković, Mirela Raos, Marta Medenjak, Branka Golubic Ćepulić
Background: Patients with hematological diseases are polytransfused and often immunocompromised, therefore susceptible to transfusion reactions (TR). This study aims to document the incidence of TRs in adult hematological patients and assess the effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c1ea5c0d18e22c9dac0f4e4840ff4b
https://www.bib.irb.hr/1216556
https://www.bib.irb.hr/1216556
Autor:
Ivana Leskovar, Sanja Mazić, Ines Bojanić, Koraljka Gojčeta, Vladimira Rimac, Anita Pavičić Bošnjak, Branka Golubić Ćepulić, Jurjana Novoselac
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0190a069d13eb2bd65b1b05c430dbc6
https://doi.org/10.1136/archdischild-2021-europaediatrics.110
https://doi.org/10.1136/archdischild-2021-europaediatrics.110
Autor:
Zorana Grubić, Drago Batinić, Ines Bojanić, Lejla Kurić, Antonija Babić, Goran Tešović, Dorian Tješić-Drinković, Jadranka Kelečić, Darko Richter, Maja Vrdoljak, Ivan Bambir, Nevenka Cigrovski
Publikováno v:
Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c9043b52f09f4b0a3fb0b6bf70cff9b
https://doi.org/10.1136/archdischild-2021-europaediatrics.155
https://doi.org/10.1136/archdischild-2021-europaediatrics.155
Publikováno v:
Journal of Clinical Apheresis. 34:407-415
Background and Objectives: The number of CD34+ cells collected in apheresis procedures depends mainly on the collection efficiency of the device and the blood volume processed. Large volume leukapheresis (LVL) can improve CD34+ cell yield and has pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c59d8d2b15459a01a33641bddb6d73b
https://doi.org/10.1002/jca.21693
https://doi.org/10.1002/jca.21693
Autor:
Antonija Babić, Lejla Kurić, Ana Zelić, null Kerep, Lana Desnica, Antonela Lelas, Milan Milošević, Ranka Serventi-Seiwerth, Nadira Duraković, Zinaida Peric, Marinka Mravak, null Stipetić, Ervina Bilic, Romana Čeović, Marko Barešić, Tamara Vukić, Dina Ljubas Kelečić, Sanja Mazić, Ines Bojanić, Ana Hećimović, Ernest Bilic, Renata Zadro, Radovan Vrhovac, Steven Z. Pavletic, Drago Batinić, Dražen Pulanić
Publikováno v:
Croatian Medical Journal
Aim: To assess the correlations of B regulatory cells (Bregs) and monocyte subsets in peripheral blood with the National Institutes of Health (NIH)-consensus-defined clinical manifestations of chronic graft-vs-host disease (cGvHD), in an attempt to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a6bc9a58c608ae720375e8486cda37
https://doi.org/10.3325/cmj.2021.62.154
https://doi.org/10.3325/cmj.2021.62.154
Publikováno v:
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 28(2)
Objectives Several studies have raised concerns that transfusion of O red blood cells (RBCs) to ABO and D non-identical recipients can intensify group O inventory shortages. The aim of this study was to retrospectively analyse particular clinical ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf3375cc6ddb5e7e0d956b84b8e24f2
https://pubmed.ncbi.nlm.nih.gov/33516888
https://pubmed.ncbi.nlm.nih.gov/33516888
Publikováno v:
Liječnički vjesnik
Volume 142
Issue 11-12
Volume 142
Issue 11-12
Daratumumab je prvo monoklonsko protutijelo anti- CD38 koje se primjenjuje u liječenju multiplog mijeloma. Njegova primjena uzrokuje panreaktivnost u testovima prijetransfuzijskog ispitivanja. Panreaktivnost je posljedica vezanja monoklonskog protut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::343c1d98862472535b3de17f4977f882
https://doi.org/10.26800/lv-142-11-12-56
https://doi.org/10.26800/lv-142-11-12-56
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.